Log in to your Inderes Free account to see all free content on this page.
BioGaia
110.50 SEK
+0.64 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioGaia
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 768.3 | 747.1 | 785.1 | 1,104.0 | 1,296.5 | 1,422.7 | 1,538.2 |
| growth-% | -2.8 % | 5.1 % | 40.6 % | 17.4 % | 9.7 % | 8.1 % | |
| EBITDA | 258.1 | 248.7 | 281.0 | 385.4 | 468.4 | 500.1 | 437.2 |
| EBIT | 242.5 | 228.2 | 253.7 | 361.5 | 443.1 | 423.4 | 412.5 |
| Profit before taxes | 242.3 | 227.6 | 252.7 | 447.6 | 468.8 | 447.8 | 421.2 |
| Net income | 187.3 | 179.7 | 196.3 | 373.6 | 365.4 | 351.4 | 332.8 |
| EPS | 2.16 | 2.01 | 1.94 | 3.70 | 3.62 | 3.48 | 3.29 |
| Dividend | 0.75 | 0.68 | 0.73 | 2.90 | 6.90 | 6.90 | 4.00 |
| Dividend ratio | 34.7 % | 33.9 % | 37.4 % | 78.4 % | 190.6 % | 198.3 % | 121.6 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 33.6 % | 33.3 % | 35.8 % | 34.9 % | 36.1 % | 35.1 % | 28.4 % |
| EBIT-% | 31.6 % | 30.5 % | 32.3 % | 32.7 % | 34.2 % | 29.8 % | 26.8 % |
| ROE | 36.9 % | 10.3 % | 10.5 % | 18.9 % | 18.0 % | 20.4 % | 25.3 % |
| ROI | 28.1 % | 9.4 % | 9.2 % | 16.9 % | 15.7 % | 17.3 % | 20.8 % |
Login required
This content is only available for logged in users